Chargement en cours...
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
Treatment of multidrug-resistant tuberculosis (MDR-TB) is extremely challenging due to the virulence of the etiologic strains of Mycobacterium tuberculosis (M. tb), the aberrant host immune responses and the diminishing treatment options with TB drugs. New treatment regimens incorporating therapeuti...
Enregistré dans:
| Publié dans: | BMC Med |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4908783/ https://ncbi.nlm.nih.gov/pubmed/27301245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-016-0635-1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|